141 related articles for article (PubMed ID: 36861837)
1. Preparation of chaperone-loaded neural stem cell-derived extracellular vesicles to reduce protein aggregation in Huntington's disease cellular models.
Joshi BS; Zuhorn IS
STAR Protoc; 2023 Mar; 4(1):102134. PubMed ID: 36861837
[TBL] [Abstract][Full Text] [Related]
2. DNAJB6, a Key Factor in Neuronal Sensitivity to Amyloidogenesis.
Thiruvalluvan A; de Mattos EP; Brunsting JF; Bakels R; Serlidaki D; Barazzuol L; Conforti P; Fatima A; Koyuncu S; Cattaneo E; Vilchez D; Bergink S; Boddeke EHWG; Copray S; Kampinga HH
Mol Cell; 2020 Apr; 78(2):346-358.e9. PubMed ID: 32268123
[TBL] [Abstract][Full Text] [Related]
3. Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation.
Rodríguez-González C; Lin S; Arkan S; Hansen C
Sci Rep; 2020 May; 10(1):8130. PubMed ID: 32424160
[TBL] [Abstract][Full Text] [Related]
4. Astrocytic expression of the chaperone DNAJB6 results in non-cell autonomous protection in Huntington's disease.
Bason M; Meister-Broekema M; Alberts N; Dijkers P; Bergink S; Sibon OCM; Kampinga HH
Neurobiol Dis; 2019 Apr; 124():108-117. PubMed ID: 30408590
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.
Meng E; Shevde LA; Samant RS
Oncotarget; 2016 Aug; 7(33):53984-53996. PubMed ID: 27276715
[TBL] [Abstract][Full Text] [Related]
6. Suppression of protein aggregation by chaperone modification of high molecular weight complexes.
Labbadia J; Novoselov SS; Bett JS; Weiss A; Paganetti P; Bates GP; Cheetham ME
Brain; 2012 Apr; 135(Pt 4):1180-96. PubMed ID: 22396390
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the molecular chaperone DNAJB6 with growing amyloid-beta 42 (Aβ42) aggregates leads to sub-stoichiometric inhibition of amyloid formation.
Månsson C; Arosio P; Hussein R; Kampinga HH; Hashem RM; Boelens WC; Dobson CM; Knowles TP; Linse S; Emanuelsson C
J Biol Chem; 2014 Nov; 289(45):31066-76. PubMed ID: 25217638
[TBL] [Abstract][Full Text] [Related]
8. Human DnaJB6 Antiamyloid Chaperone Protects Yeast from Polyglutamine Toxicity Separately from Spatial Segregation of Aggregates.
Kumar J; Kline NL; Masison DC
Mol Cell Biol; 2018 Dec; 38(23):. PubMed ID: 30224519
[TBL] [Abstract][Full Text] [Related]
9. The Molecular Chaperone DNAJB6, but Not DNAJB1, Suppresses the Seeded Aggregation of Alpha-Synuclein in Cells.
Deshayes N; Arkan S; Hansen C
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514384
[TBL] [Abstract][Full Text] [Related]
10. The roles of HSP40/DNAJ protein family in neurodegenerative diseases.
He Y; Wang Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):640-646. PubMed ID: 36581576
[TBL] [Abstract][Full Text] [Related]
11. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
[TBL] [Abstract][Full Text] [Related]
12. DnaJB6 is present in the core of Lewy bodies and is highly up-regulated in parkinsonian astrocytes.
Durrenberger PF; Filiou MD; Moran LB; Michael GJ; Novoselov S; Cheetham ME; Clark P; Pearce RK; Graeber MB
J Neurosci Res; 2009 Jan; 87(1):238-45. PubMed ID: 18711724
[TBL] [Abstract][Full Text] [Related]
13. Huntington's disease: fighting on many fronts.
Andre R; Wild EJ; Tabrizi SJ
Brain; 2012 Apr; 135(Pt 4):998-1001. PubMed ID: 22427330
[No Abstract] [Full Text] [Related]
14. Myofibrillar disruption and RNA-binding protein aggregation in a mouse model of limb-girdle muscular dystrophy 1D.
Bengoechea R; Pittman SK; Tuck EP; True HL; Weihl CC
Hum Mol Genet; 2015 Dec; 24(23):6588-602. PubMed ID: 26362252
[TBL] [Abstract][Full Text] [Related]
15. DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in
Joshi BS; Youssef SA; Bron R; de Bruin A; Kampinga HH; Zuhorn IS
iScience; 2021 Nov; 24(11):103282. PubMed ID: 34755099
[TBL] [Abstract][Full Text] [Related]
16. Myopathy-causing mutations in an HSP40 chaperone disrupt processing of specific client conformers.
Stein KC; Bengoechea R; Harms MB; Weihl CC; True HL
J Biol Chem; 2014 Jul; 289(30):21120-30. PubMed ID: 24920671
[TBL] [Abstract][Full Text] [Related]
17. Conserved S/T Residues of the Human Chaperone DNAJB6 Are Required for Effective Inhibition of Aβ42 Amyloid Fibril Formation.
Månsson C; van Cruchten RTP; Weininger U; Yang X; Cukalevski R; Arosio P; Dobson CM; Knowles T; Akke M; Linse S; Emanuelsson C
Biochemistry; 2018 Aug; 57(32):4891-4902. PubMed ID: 30024736
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-β oligomers are captured by the DNAJB6 chaperone: Direct detection of interactions that can prevent primary nucleation.
Österlund N; Lundqvist M; Ilag LL; Gräslund A; Emanuelsson C
J Biol Chem; 2020 Jun; 295(24):8135-8144. PubMed ID: 32350108
[TBL] [Abstract][Full Text] [Related]
19. The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides.
Gillis J; Schipper-Krom S; Juenemann K; Gruber A; Coolen S; van den Nieuwendijk R; van Veen H; Overkleeft H; Goedhart J; Kampinga HH; Reits EA
J Biol Chem; 2013 Jun; 288(24):17225-37. PubMed ID: 23612975
[TBL] [Abstract][Full Text] [Related]
20. Identification of a HTT-specific binding motif in DNAJB1 essential for suppression and disaggregation of HTT.
Ayala Mariscal SM; Pigazzini ML; Richter Y; Özel M; Grothaus IL; Protze J; Ziege K; Kulke M; ElBediwi M; Vermaas JV; Colombi Ciacchi L; Köppen S; Liu F; Kirstein J
Nat Commun; 2022 Aug; 13(1):4692. PubMed ID: 35948542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
